Sustainable chemotherapy schedules

Mostrar todas las versiones(2)

We used a discrete time version of viabilitytheory in order to study the sustainable therapies againstthe cancer. We assume that the tumor is composed of twosubpopulations, one resistant and the another sensitive. Weconsider a discrete model in order to simulate the responseof this tumor to therapy,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Barrea, Andrés Alberto, Hernández, Matias Ezequiel
Formato:	conferenceObject submittedVersion
Lenguaje:	Inglés
Publicado:	2021
Materias:	Chemotherapy Cancer Bellman Tumor Viability
Acceso en línea:	http://hdl.handle.net/11086/22070
Aporte de:	Repositorio Digital Universitario (UNC) de Universidad Nacional de Córdoba

Ejemplares similares

Sustainable chemotherapy schedules
por: Barrea, Andrés Alberto, et al.
Publicado: (2021)

Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
por: Perroud, Herman A, et al.
Publicado: (2018)

Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients
por: Perroud, Herman A, et al.
Publicado: (2018)

Comparative Effectiveness of Two Metronomic Chemotherapy Schedules. Our Experience in the Preclinical Field
por: Rico, María José, et al.
Publicado: (2018)

The Immune Response and the Therapeutic Effect of Metronomic Chemotherapy With Cyclophosphamide
por: Rozados, Viviana R., et al.
Publicado: (2012)

Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response
por: Perroud, Herman A, et al.
Publicado: (2018)

The understanding of information about oral chemotherapy treatment among outpatients at a University Hospital in Ceará, Brazil
por: Pereira, Ana G. da S., et al.
Publicado: (2010)

Quimioterapia antineoplásica en pacientes internados
por: Boquete, Alejandra L.
Publicado: (1993)

Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer
por: Perroud, Herman A, et al.
Publicado: (2018)

Metronomic chemotherapy: changing the paradigm that more is better
por: Scharovsky, O. Graciela, et al.
Publicado: (2012)

Chemotherapy :

A Symmetrical Dirhenium(I) Complex with 4,4’’-Azobis(2,2’-bipyridine) as a Bridging Ligand: Synthesis, Physicochemical Properties and Applications in Detection of Biologically Relevant Thiols and in Chemotherapy for Bone Cancer
por: Abate, Pedro Oscar, et al.
Publicado: (2020)

Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24–25 June 2014, Milan
por: Bouche, Gauthier, et al.
Publicado: (2018)

Achievements and challenges in the use of metronomics for the treatment of breast cancer
por: Scharovsky, O. Graciela, et al.
Publicado: (2020)

Rol de la inflamación sistémica en la patología generada por tumores murinos
por: Bruzzo Iraola, Juan
Publicado: (2014)

Rol de la inflamación sistémica en la patología generada por tumores murinos
por: Bruzzo Iraola, Juan
Publicado: (2014)

Rol de la inflamación sistémica en la patología generada por tumores murinos
por: Bruzzo Iraola, Juan
Publicado: (2013)

A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma
Publicado: (1999)

A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma
por: Blajman, C., et al.

Radiobiological research and radiotherapy : proceedings of an International Symposium on the Radiobiological Research Needed for the Improvement of Radiotherapy held by the International Atomic Energy Agency in Vienna, 22-26 November 1976.
Publicado: (1977)

Nuevos blancos para tratar el cáncer.
por: Valette, Annie

Addition of vasopressin synthetic analogue [V<sup>4</sup>Q<sup>5</sup>]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models
por: Garona, Juan, et al.
Publicado: (2016)

Optimal reinsurance and dividend distribution policies in the cramér-lundberg model
Publicado: (2005)

Optimal reinsurance and dividend distribution policies in the cramér-lundberg model
por: Azcue, P., et al.

Las semillas del cáncer.
por: Coluccio Leskow, Federico

Contribution of fotemustine in the treatment of primary brain tumors: Clinical overview
Publicado: (1996)

Contribution of fotemustine in the treatment of primary brain tumors: Clinical overview
por: Schmilovich, A.

GNAI1 and GNAI3 reduce colitis-associated tumorigenesis in mice by blocking IL6 signaling and down-regulating expression of GNAI2
por: Li, Zhi-Wei, et al.
Publicado: (2019)

Rol de BRCA1 en la regulación de la transcripción en cáncer de próstata
por: De Luca, Paola
Publicado: (2011)

Rol de BRCA1 en la regulación de la transcripción en cáncer de próstata
por: De Luca, Paola
Publicado: (2011)

Rol de BRCA1 en la regulación de la transcripción en cáncer de próstata
por: De Luca, Paola
Publicado: (2011)

Self-assembly of carrageenin–CaCO3 hybrid microparticles on bacterial cellulose films for doxorubicin sustained delivery
por: Cacicedo, Maximiliano Luis, et al.
Publicado: (2015)

Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity
Publicado: (2018)

Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity
por: Corapi, E., et al.

Circadian disruption induced by tumor development in a murine model of melanoma
por: Aiello, Ignacio, et al.
Publicado: (2021)

Histamine receptors and cancer pharmacology : an update
por: Massari, Noelia A., et al.
Publicado: (2019)

Hyperandrogenism produced by ovarian tumors in women at different life stages.
por: Fuox-Otta, Carolina, et al.
Publicado: (2014)

Coexpresión de los receptores de la familia de ERBB y DDR1 en la glándula mamaria tumoral. Un metaanálisis bioinformático
por: Aguilera, Pablo Nicolás
Publicado: (2022)

Hyperandrogenism produced by ovarian tumors in women at different life stages.
por: Fuox-Otta, Carolina, et al.
Publicado: (2014)

Las metástasis de los cánceres.
por: Salomon, Jean-Claude